Vivani Medical subsidiary Cortigent announced the results of a study evaluating its Orion visual cortical prosthesis system.
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology . Cortigent is the ...
Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...
EMERYVILLE, Calif.--(BUSINESS WIRE)-- Vivani Medical, Inc. (NASDAQ: VANI), an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic ...
SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...
Blindness affects millions of people worldwide and severely limits their independence, daily functioning, and overall quality of life. In Spain, the prevalence of blindness is estimated at 0.17% , ...
Vivani Medical plans to spin off Cortigent, allowing both companies to focus on their specialized therapeutic areas by Q3 2025. Vivani Medical, Inc. has announced plans to spin off its subsidiary, ...
Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...
Neuralink nears human trials for Blindsight, a revolutionary brain implant promising to restore sight to the blind. Learn how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results